Urethral Dilators Market Trends

Growth Drivers

• Spiking Cases of Prostate Cancer – In some cases, prostate cancer may lead to urethral strictures, which necessitate the use of urology devices including urethral dilators to manage urinary function. For instance, depending on the type of cancer treatment used, there is more than a 5% risk of urethral stricture after prostate cancer therapy. In 2020, there were over 1 million new cases of prostate cancer detected worldwide.
• Growing Geriatric Population- Aged people may have weakened immune systems which can decrease the capacity of the bladder and weaken the pelvic floor muscles. This can lead to several urological disorders, leading to increased demand for urethral dilators. Lately, the number of individuals over 65 across the globe is more than 610 million, or roughly 8% of the population.

Challenges

• Availability of Alternative Treatment Options – There are many other treatment options such as laser therapies, behavioral therapy, medication, surgical options for rUTI management, and endoscopic or percutaneous are easily available for the treatment of urological condition. This, as a result, limits the adoption of urethral dilators.
• Stringent Regulatory Standards
• Lack of Awareness